Cationic lipid-mediated transfection of cells in culture requires mitotic activity I Mortimer, P Tam, I MacLachlan, RW Graham, EG Saravolac, PB Joshi Gene therapy 6 (3), 403-411, 1999 | 352 | 1999 |
Catalytic nucleic acids: from lab to applications LQ Sun, MJ Cairns, EG Saravolac, A Baker, WL Gerlach Pharmacological Reviews 52 (3), 325-348, 2000 | 231 | 2000 |
Cellular uptake, distribution, and stability of 10-23 deoxyribozymes CR Dass, EG Saravolac, Y Li, LQ Sun Antisense and Nucleic Acid Drug Development 12 (5), 289-299, 2002 | 182 | 2002 |
Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies R Bhindi, RG Fahmy, HC Lowe, CN Chesterman, CR Dass, MJ Cairns, ... The American journal of pathology 171 (4), 1079-1088, 2007 | 178 | 2007 |
Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties YP Zhang, L Sekirov, EG Saravolac, JJ Wheeler, P Tardi, K Clow, E Leng, ... Gene therapy 6 (8), 1438-1447, 1999 | 177 | 1999 |
Prophylactic and therapeutic efficacies of poly (IC. LC) against respiratory influenza A virus infection in mice JP Wong, EG Saravolac, D Sabuda, HB Levy, M Kende Antimicrobial agents and chemotherapy 39 (11), 2574-2576, 1995 | 77 | 1995 |
Catalytic DNA: a novel tool for gene suppression MJ Cairns, EG Saravolac, LQ Sun Current Drug Targets 3 (3), 269-279, 2002 | 73 | 2002 |
Purification of glucose-inducible outer membrane protein OprB of Pseudomonas putida and reconstitution of glucose-specific pores EG Saravolac, NF Taylor, R Benz, RE Hancock Journal of bacteriology 173 (16), 4970-4976, 1991 | 63 | 1991 |
Encapsulation of plasmid DNA in stabilized plasmid–lipid particles composed of different cationic lipid concentration for optimal transfection activity EG Saravolac, O Ludkovski, R Skirrow, M Ossanlou, YP Zhang, ... Journal of drug targeting 7 (6), 423-437, 2000 | 55 | 2000 |
Methods for encapsulating nucleic acids in lipid bilayers EG Saravolac, YP Zhang, JJ Wheeler, PR Cullis, P Scherrer, LD Kojic, ... US Patent 6,734,171, 2004 | 54 | 2004 |
Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody. JP Wong, LL Stadnyk, EG Saravolac Immunology 81 (2), 280, 1994 | 41 | 1994 |
Immunoprophylactic strategies against respiratory influenza virus infection EG Saravolac, D Sabuda, C Crist, K Blasetti, G Schnell, H Yang, M Kende, ... Vaccine 19 (17-19), 2227-2232, 2001 | 30 | 2001 |
Liposome-encapsulated ciprofloxacin for the prevention and treatment of infectious diseases caused by intracellular pathogens JP Wong, JW Cherwonogrodzky, VL Di Ninno, R De la Cruz, ... Liposomes in Biomedical Applications, Shek ed, Harwood Academic Pub, 105-120, 1995 | 24 | 1995 |
Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-γ EG Saravolac, B Kournikakis, L Gorton, JP Wong Antiviral research 29 (2-3), 199-207, 1996 | 22 | 1996 |
Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme X Yu, L Yang, MJ Cairns, C Dass, E Saravolac, X Li, LQ Sun Oncotarget 5 (19), 9039, 2014 | 19 | 2014 |
Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza JP Wong, ME Christopher, AM Salazar, LQ Sun, S Viswanathan, M Wang, ... Front Biosci (Schol Ed) 2, 791-800, 2010 | 19 | 2010 |
Recent patents in antiviral siRNAs EG Saravolac, JP Wong, MJ Cairns Recent patents on anti-infective drug discovery 5 (1), 44-57, 2010 | 9 | 2010 |
Recent patents on development of nucleic acid-based antiviral drugs against seasonal and pandemic influenza virus infections EG Saravolac, JP Wong Recent Patents on Anti-Infective Drug Discovery 2 (2), 140-147, 2007 | 9 | 2007 |
Glucose transport: probing the structure/function relationship EG Saravolac, GD Holman Facilitative glucose transporters. Landes, Georgetown, 39-66, 1997 | 8 | 1997 |
Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug JP Wong, EG Saravolac, LP Nagata US Patent 5,968,548, 1999 | 5 | 1999 |